ACM
EXAS

Advent Capital Management’s Exact Sciences EXAS Stock Holding History

Advent Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-50
Closed -$1K – 220
2019
Q3 		$1K Buy
+50
New +$5.7K ﹤0.01% 212

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Advent Capital Management's EXAS Position: Q2 2021 in Review

Advent Capital Management sold out of Exact Sciences (EXAS) in Q2 2021, closing a stake of 39 shares — an estimated $5K sold.

Advent Capital Management first reported a position in EXAS in Q1 2021 and held it in 1 quarter. The position peaked at $5K in Q1 2021. 623 funds tracked by Wall St. Rank hold EXAS as of Q2 2021.

  • Advent Capital Management reported no remaining Exact Sciences position as of Q2 2021 after selling out during the quarter.
  • Advent Capital Management sold 39 Exact Sciences shares in Q2 2021, an estimated $5K.
  • Advent Capital Management first reported a position in Exact Sciences in Q1 2021 and held it in 1 quarter.
  • Advent Capital Management's Exact Sciences position peaked at $5K in Q1 2021.
  • 623 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2021.

Based on Advent Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.